Form 4: Aveanna Healthcare Director Affiliates Sell 1.5M Shares

Aveanna Healthcare Holdings, Inc. director Robert M. Williams Jr. reported the sale of 1,499,000 shares of common stock by affiliated entities at $9 per share.

Summary

• Robert M. Williams Jr., a Director and 10% Owner of Aveanna Healthcare Holdings, Inc. (AVAH), reported changes in beneficial ownership.
• Affiliated entities sold a total of 1,499,000 shares of common stock on October 24, 2025, at a price of $9 per share.
• The sales were executed pursuant to the option to purchase additional shares in an underwritten secondary offering.
• The transactions were made under a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities.
• Following these transactions, the affiliated entities continue to beneficially own a significant number of shares: J.H. Whitney VII, L.P. (19,292,787 shares), PSA Healthcare Investment Holdings LLC (15,523,809 shares), JHW Iliad Holdings LLC (3,460,515 shares), PSA Iliad Holdings LLC (1,426,034 shares), and JHW Iliad Holdings II LLC (362,746 shares).
• Mr. Williams disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can sometimes be viewed negatively, the fact that these sales were part of a pre-arranged 10b5-1 plan and an underwritten secondary offering mitigates concerns about opportunistic selling or a negative outlook on the company's future.

Positives

• The sales were conducted under a Rule 10b5-1(c) plan, indicating a pre-arranged, orderly disposition of shares rather than a reaction to new, undisclosed negative information, which provides transparency.
• The transactions were part of an underwritten secondary offering, suggesting an organized market process for the sale of shares.

Negatives

• Significant insider selling, even if planned, can sometimes be perceived by the market as a lack of conviction by large shareholders, potentially increasing the supply of shares in the market.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing reports an insider transaction and does not provide information directly related to broader industry trends or competitive landscape for Aveanna Healthcare Holdings, Inc.

Related Party Transactions

• The sales were conducted by entities (J.H. Whitney VII, L.P., JHW Iliad Holdings LLC, JHW Iliad Holdings II LLC) with which Robert M. Williams Jr., a Director and 10% Owner, is affiliated and may be deemed to share voting and dispositive power.

Stakeholder Impact

• Shareholders may observe an increase in the public float of shares due to the secondary offering.
• The market might interpret the insider selling, even if planned, as a signal, though the 10b5-1 plan reduces the negative implications.

Key Dates

Recommendation

The filing reports a planned sale of shares by entities affiliated with a director and 10% owner. While significant, the pre-arranged nature of the sale (10b5-1 plan) and its execution as part of a secondary offering suggest a structured disposition rather than a reaction to new, adverse company-specific information. This transaction alone does not provide sufficient new fundamental information to warrant a change in investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

Aveanna Healthcare, AVAH, Form 4, Insider Transaction, Stock Sale, Robert M. Williams Jr., J.H. Whitney, 10b5-1 Plan, Secondary Offering